We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

126 hedge funds and large institutions have $422M invested in CytomX Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more capital invested

Capital invested by funds: $249M → $422M (+$173M)

53% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 34

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

2.1% more ownership

Funds ownership: 82.21% → 84.31% (+2.1%)

0% more funds holding

Funds holding: 126 → 126 (0)

25% less call options, than puts

Call options by funds: $563K | Put options by funds: $746K

Holders
126
Holders Change
–
Holders Change %
0%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
52
Reduced
34
Closed
20
Calls
$563K
Puts
$746K
Net Calls
-$183K
Net Calls Change
-$271K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$49.2M
2
RCM
RA Capital Management
Massachusetts
+$27.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$13.7M
4
BlackRock
BlackRock
New York
+$11M
5
State Street
State Street
Massachusetts
+$10.4M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.84M
2
PA
Perceptive Advisors
New York
-$3.35M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.35M
4
Morgan Stanley
Morgan Stanley
New York
-$2.3M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$3.66M +$875K +110,581 +30%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.46M -$2.35M -297,518 -48%
Janus Henderson Group
28
Janus Henderson Group
United Kingdom
$2.42M +$2.47M +312,667 New
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$2.27M +$295K +37,218 +15%
Goldman Sachs
30
Goldman Sachs
New York
$1.62M -$145K -18,347 -8%
Assenagon Asset Management
31
Assenagon Asset Management
Luxembourg
$1.58M -$116K -14,622 -7%
Citigroup
32
Citigroup
New York
$1.58M +$1.53M +192,708 +1,683%
PVI
33
Pura Vida Investments
New York
$1.56M +$1.6M +202,478 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.52M +$165K +20,825 +12%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$1.42M -$346K -43,734 -19%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$1.26M +$1.16M +145,950 +874%
Wells Fargo
37
Wells Fargo
California
$1.12M +$356K +44,940 +45%
Barclays
38
Barclays
United Kingdom
$1.06M +$374K +47,290 +53%
VRS
39
Virginia Retirement Systems
Virginia
$1.01M +$818K +103,300 +372%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$985K +$895K +113,099 +788%
AGA
41
Altrinsic Global Advisors
Connecticut
$928K +$950K +120,000 New
Swiss National Bank
42
Swiss National Bank
Switzerland
$898K +$176K +22,200 +24%
GC
43
Globeflex Capital
California
$894K +$366K +46,212 +67%
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$850K +$806K +101,871 +1,460%
AQR Capital Management
45
AQR Capital Management
Connecticut
$781K -$181K -22,921 -18%
BFM
46
Boothbay Fund Management
New York
$737K +$754K +95,284 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$718K +$196K +24,805 +36%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$713K +$267K +33,764 +58%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$707K -$68.2K -8,612 -9%
SO
50
STRS Ohio
Ohio
$687K – – –
1
2
3 4 5

CTMX Hedge Fund Activity: Q1 2021 in Review

126 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q1 2021, worth a combined $422M — up 70% from $249M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CTMX positions and 20 closed out — a net gain of 2 holders — while 52 added to existing stakes and 34 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $49.2M. The largest seller was Renaissance Technologies, cutting an estimated $4.84M.

  • 126 institutional investors held CytomX Therapeutics (CTMX) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $422M of CytomX Therapeutics stock for Q1 2021, up 70% quarter-over-quarter.
  • 22 funds opened new CytomX Therapeutics positions in Q1 2021 and 20 closed out, a net change of +2 holders.
  • The largest CytomX Therapeutics buyer in Q1 2021 was Point72 Asset Management, an estimated $49.2M added.
  • The largest CytomX Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $4.84M sold.

Based on aggregated 13F filings for Q1 2021.